Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Correction: Randomized Controlled Trial of RTS,S/AS02D and RTS,S/AS01E Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children.
Owusu-Agyei, S; Ansong, D; Asante, K; Kwarteng Owusu, S; Owusu, R; Wireko Brobby, NA; Dosoo, D; Osei Akoto, A; Osei-Kwakye, K; Adjei, EA; Boahen, KO; Sylverken, J; Adjei, G; Sambian, D; Apanga, S; Kayan, K; Vekemans, J; Ofori-Anyinam, O; Leach, A; Lievens, M; Demoitie, M-A; Dubois, M-C; Cohen, J; Ballou, WR; Savarese, B; ... Evans, J.
2010
PloS one, (2010).5 11
Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster.
Russell, FM; Carapetis, JR; Satzke, C; Tikoduadua, L; Waqatakirewa, L; Chandra, R; Seduadua, A; Oftadeh, S; Cheung, YB; Gilbert, GL; MULHOLLAND, EK;
2010
Clinical and vaccine immunology, (2010).17 12 10.1128/CVI.00117-10.
Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial.
Benn, CS; Fisker, AB; Napirna, BM; Roth, A; Diness, BR; Lausch, KR; Ravn, H; Yazdanbakhsh, M; Rodrigues, A; WHITTLE, H; Aaby, P;
2010
BMJ (Clinical research ed), (2010).340 mar09 10.1136/bmj.c1101.
ISOLATION OF VIABLE PLASMODIUM FALCIPARUM MEROZOITES TO DEFINE ERYTHROCYTE INVASION EVENTS AND ADVANCE VACCINE AND DRUG DEVELOPMENT.
Boyle, MJ; Wilson, DW; Richards, JS; Riglar, DT; Tetteh, KK; CONWAY, DJ; Ralph, SA; Baum, J; Beeson, JG;
2010
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, (2010).83 5
Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience.
Hajjeh, RA; Privor-Dumm, L; EDMOND, K; O'Loughlin, R; Shetty, S; GRIFFITHS, UK; Bear, AP; COHEN, AL; Chandran, A; Schuchat, A; MULHOLLAND, EK; Santosham, M;
2010
Vaccine, (2010).28 43 10.1016/j.vaccine.2010.07.028.
Failure to vaccinate or failure of vaccine? Effectiveness of the 23-valent pneumococcal polysaccharide vaccine program in Indigenous adults in the Northern Territory of Australia.
Moberley, S; Krause, V; Cook, H; MULHOLLAND, K; Carapetis, J; Torzillo, P; Andrews, R;
2010
Vaccine, (2010).28 11 10.1016/j.vaccine.2009.12.066.
Comparative Critical Review of Cost-Effectiveness Tools of Pneumococcal Conjugate Vaccine (Pcv).
Chaiyakunapruk, N; Somkrua, R; Hutubessy, R; Restrepo, AM H; Melegaro, A; EDMUNDS, J; Beutels, P;
2010
Value in health, (2010).13 7
Global use of Haemophilus influenzae type b conjugate vaccine.
Ojo, LR; O'Loughlin, RE; COHEN, AL; Loo, JD; EDMOND, KM; Shetty, SS; Bear, AP; Privor-Dumm, L; GRIFFITHS, UK; Hajjeh, R;
2010
Vaccine, (2010).28 43 10.1016/j.vaccine.2010.07.074.
Prevalence and characteristics of asymptomatic norovirus infection in the community in England.
Phillips, G; Tam, CC; RODRIGUES, LC; Lopman, B;
2010
Epidemiology and infection, (2010).138 10 10.1017/S0950268810000439.
Design of a Phase IIb, randomized, controlled, double-blind, multi-centre study to evaluate the efficacy, safety, and immunogenicity of the GMZ2 candidate malaria vaccine in Ugandan, Ghanaian, Burkinabe and Gabonese children aged 12-60 months.
Noor, RA; Thiesen, M; Mordmuller, B; MILLIGAN, P; Atuguba, F; Sirima, S; Issifou, S; BOJANG, K; Kironde, F; Tiono, A; Okech, B; Chilengi, R; Ngoa, A; Mukasa, K; Jepsen, S;
2010
Malaria journal, (2010).9 Suppl 2 10.1186/1475-2875-9-s2-p26.